NewslettersCell Therapy NewsDominant-Negative Transforming Growth Factor-β Receptor-Armoured Mesothelin-Targeted Chimeric Antigen Receptor T Cells Slow Tumour Growth in a Mouse Model of Ovarian CancerBy Bob - October 3, 20220195The in vivo antitumour activity of mesothelin CAR T cells was verified using a patient-derived xenograft mouse model with human tumour-derived cells.[Cancer Immunology, Immunotherapy]Full Article